- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Dutch Pharmacists Could Offer Pharmacogenetics Services by 2020
October 05, 2015.
Community pharmacists in the Netherlands could offer pharmacogenetics testing, therapeutic support, and advice in as little as 5 years, according to the International Pharmaceutical Federation (FIP).
A plan to implement pharmacogenomics in primary care was launched by the Royal Dutch Pharmacists Association (KNMP) and the Dutch Hospital Pharmacists Association (NVZA) at the World Congress of Pharmacy and Pharmaceutical Sciences last week.
Since 2005, KNMP’s working group on pharmacogenetics has developed recommendations for 80 gene-drug combinations, which are now integrated into the nationwide drug database incorporated into all electronic systems for prescribing and dispensing.
The plan is now in exploration phase and pilot pharmacogenomics laboratory tests by pharmacists and primary care stakeholder analysis are due to start later this year, it is reported.
